CLINICAL_TRIALS
trial_result
· 2012-01-09
Clinical Trial Update: Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease [Phase 3]
Summary
Phase 3 trial results for memantine in moderate-to-severe Alzheimer's disease were posted after the study was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Alzheimer's Disease | Phase 3 | Status: TERMINATED | Results posted: 2012-01-09